[1]
Gottlieb, A., Thaci, D., Leonardi, C., Poulin, Y., Kavanagh, S., Boehnlein, M. and Reich, K. 2019. Nail Outcome Improvements with Certolizumab Pegol in Moderate to Severe Plaque Psoriasis: Results from Phase 3 Trials. SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S38. DOI:https://doi.org/10.25251/skin.3.supp.38.